E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/15/2006 in the Prospect News Biotech Daily.

FDA Calendar

March 16-18, Kanawaza, Japan

21st ANNUAL MEETING OF THE ACADEMY OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY

Includes presentation from Scolr Pharma Inc. on approaches to conventional oral drug delivery

March 16-18, Amsterdam

4th INTERNATIONAL SYMPOSIUM ON TARGETED ANTI-CANCER THERAPIES

Includes presentation from Array BioPharma Inc. on ARRY-649, a KSP inhibitor

March 16-19, Dallas

ANNUAL SYMPOSIUM OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION

Includes presentation from Nymox Pharmaceutical Corp. on clinical study data for AlzheimAlert, a urine-based diagnostic aid for Alzheimer's disease

March 17, Gaithersburg, Md.

CIRCULATORY SYSTEM DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE (FDA)

Committee to discuss and make recommendations on premarket notification submission for use in the induction, maintenance and reversal of mild hypothermia in the treatment of unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest when initial rhythm was ventricular fibrillation

March 17-18, Gaithersburg, Md.

BLOOD PRODUCTS ADVISORY COMMITTEE (FDA)

Committee to hear updates on summary of Department of Health and Human Services Advisory Committee on Blood Safety and Availability meeting; summary of the Transmissible Spongiform Encephalopathies Advisory Committee meeting; update on West Nile Virus guidance; summaries of the Critical Path Initiative workshop; recommendations on the safety of albumin; updates on international agreements and a presentation on sharing information with the public

March 23, Gaithersburg, Md.

NONPRESCRIPTION DRUGS ADVISORY COMMITTEE (FDA)

Committee to discuss microbiologic surrogate endpoints used to demonstrate effectiveness of antiseptic products used in health care settings

March 24, Gaithersburg, Md.

JOINT MEETING OF THE DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEE AND THE NONPRESCRIPTION DRUGS ADVISORY COMMITTEE (FDA)

Committee to discuss necessary and sufficient safety database to evaluate prescription to over-the-counter switch of topical corticosteroids, particularly for the potential of hypothalamic, pituitary, adrenal and growth suppression

April 1-5, Washington

2006 AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING

Includes presentation from Ariad Pharmaceuticals Inc. on development pipeline and AP23573 for soft-tissue and bone sarcomas; presentation from Chemokine Therapeutics Corp. on preclinical study of CTCR-9908 anticancer compound in prostate cancer model and presentation from Oncolytics Biotech Inc. on phase 1 combination Reolysin/radiation clinical trial results

April 1-8, San Diego

58th AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

Includes presentation from CepTor Corp. on abstract for Myodur calpain inhibitor for Duchenne Muscular Dystrophy

April 6-8, Mannheim, Germany

EORTC SOFT TISSUE AND BONE SARCOMA GROUP MEETING

Includes presentation from Ariad Pharmaceuticals Inc. on development pipeline and AP23573 for soft-tissue and bone sarcomas

April 7, Bethesda, Md.

ALLERGENIC PRODUCTS ADVISORY COMMITTEE MEETING (FDA)

Includes discussion on proposed strategy for reclassification of class IIIA allergenic products, update of the FDA critical path initiative

April 11-13, Gaithersburg, Md.

GENERAL AND PLASTIC SURGERY DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE (FDA)

Includes oral presentations from public, discussion, recommendations and vote on two premarket approval applications for silicone gel-filled breast prostheses

April 15, Rockville, Md.

SCIENCE BOARD TO THE FOOD AND DRUG ADMINISTRATION MEETING

Discussion and presentation on agency's pre- and post-marketing safety programs for drugs and biologics and good manufacturing practices for vaccines, blood and cell, tissue and gene products

April 19-22, Geneva, Switzerland

9th INTERNATIONAL GENEVA/SPRINGFIELD SYMPOSIUM ON ADVANCES IN ALZHEIMER THERAPY

Includes presentations from Axonyx Inc. on Phenserine and Posiphen

April 22, Gaithersburg, Md.

CIRCULATORY SYSTEM DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE (FDA)

Includes presentation by the Office of Surveillance and Biometrics on its review of post-market study design, update on recently purchased devices, recommendations on premarket notification submission for coronary proximal anastomosis device

April 26-30, Vienna, Austria

41st ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

Includes presentations on liver transplantation, cirrhosis, tumors and viral hepatitis

May 7-11, San Juan, Puerto Rico

19th INTERNATIONAL CONFERENCE ON ANTIVIRAL RESEARCH

Includes presentations on antiviral drug and antiviral chemotherapy research

May 15-20, Toronto

ANNUAL MEETING OF THE AMERICAN PSYCHIATRIC ASSOCIATION

Includes presentation from Nymox Pharmaceutical Corp. on AlzheimAlert, a urine-based diagnostic aid, and its successful clinical studies

May 17, Gaithersburg, Md.

PERIPHERAL AND CENTRAL NERVOUS SYSTEM DRUGS ADVISORY COMMITTEE MEETING (FDA)

Includes discussion on Novartis Pharmaceuticals Corp.'s supplemental New Drug Application 20823, SE1-016, Exelon capsules for mild to moderate dementia associated with Parkinson's disease

May 17-18, Baltimore

INDUSTRY EXCHANGE WORKSHOP ON FOOD AND DRUG ADMINISTRATION CLINICAL TRIAL REQUIREMENTS

Public workshop in cooperation with the Society of Clinical Research Associates on FDA clinical trial statutory and regulatory requirements

May 20-25, Los Angeles

DIGESTIVE DISEASE WEEK CONFERENCE

Includes presentation from Callisto Pharmaceuticals Inc. on Guanilib for gastrointestinal inflammation

June 2-6, Atlanta

2006 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING

Includes presentation from Cell Genesys Inc. on trial of GM-CSF-gene transduced allogeneic prostate cancer cellular immunotherapy with human anti-CTLA-4 antibody for hormone-refractory prostate cancer and K562/GM-CSF vaccination for tumor burden related to chronic myelogenous leukemia

July 12-15, Washington

13th WORLD CONFERENCE ON TOBACCO OR HEALTH

Includes presentation from Nymox Pharmaceutical Corp. on results for saliva NicAlert test for tobacco exposure


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.